Ocular Therapeutix Price Target Raised to $30 from $20 at JMP Securities
December 30, 2020 at 09:30 AM EST
JMP Securities analyst Jonathan Wolleben raised the firm's price target on Ocular Therapeutix to $30 from $20 and reiterates an Outperform rating on the shares.
